Academic Psychiatry

, Volume 42, Issue 2, pp 269–272 | Cite as

The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine

  • Anna Lembke
  • Keith Humphreys
In Depth Article: Commentary

Since at least 1784, when the American physician, civic leader, and iconoclast Benjamin Rush first published Inquiry into the Effects of Ardent Spirits on the Human Mind and Body, individuals inside and outside of medicine have advocated for the recognition of addiction as a disease meriting medical treatment. In medical schools and residencies, Rush’s plea fell largely on deaf ears. Medical schools have historically provided little in the way of training for the diagnosis and treatment of addiction. According to the 2012 National Center on Addiction and Substance Abuse report, most medical schools offer only a few hours of addiction training over 4 years [1]. The opioid epidemic, however, which now exceeds HIV/AIDS in its catastrophic effects, has rattled the medical establishment out of complacency, providing new opportunities to equip American physicians with the knowledge to respond to addiction as a legitimate and treatable medical disorder.

This paper reviews milestones in...


Compliance with Ethical Standards

This commentary did not involve human subjects.


On behalf of both authors, the corresponding author states that there is no conflict of interest.


  1. 1.
    CASAColumbia, ed. Addiction Medicine: Closing the Gap between Science and Practice. Published 2012. Available from: Accessed 1/30/18.
  2. 2.
    The Hazelden Betty Ford Foundation. Summer Institute for Medical Students (SIMS). Available from: Accessed 1/30/18.
  3. 3.
    Lembke A. Drug Dealer, MD: How doctors were duped, patients got hooked, and why it’s so hard to stop. 1st ed. Johns Hopkins University Press; 2016.Google Scholar
  4. 4.
    Antman KH, Berman HA, Flotte TR, Flier J, Dimitri DM, Core Competencies BM. For the prevention and management of prescription drug misuse: a medical education collaboration in Massachusetts. Acad Med. 2016;91(10):1348–51. Scholar
  5. 5.
    Accreditation Council for Graduate Medical Education. Addiction psychiatry programs: academic year 2017–2018. Available from: Accessed 1/30/18.
  6. 6.
    Chen J. The patient you least want to see. JAMA. 2016;315(16):1701–2. Scholar
  7. 7.
    Komaromy M, Duhigg D, Metcalf A, Carlson C, Kalishman S, Hayes L, et al. Project ECHO (extension for community healthcare outcomes): a new model for educating primary care providers about treatment of substance use disorders. Subst Abus. 2016;37(1):20–4. Scholar
  8. 8.
    Humphreys K, Frank RG. The Affordable Care Act will revolutionize the care of substance use disorders in the United States. Addiction. 2014;109(12):1957–8. Scholar
  9. 9.
    Humphreys K. Growth in Drug Treatment Has led to more innovation. New York Times. 2016. Available from: Accessed 1/30/18.
  10. 10.
    Grogan CM, Andrews C, Abraham A, Pollack H, Smith B, Humphreys K, et al. Survey highlights differences in Medicaid coverage for substance use disorder treatment and opioid use disorder medications. Health Aff. 2016;35(12):2289–96. Scholar

Copyright information

© Academic Psychiatry 2018

Authors and Affiliations

  1. 1.Stanford UniversityStanfordUSA

Personalised recommendations